Abiopharma

Clinical trial NCT06800313 updates: 1. start date: 2025-02-20 → 2025-02-06 2. completion date: 2030-04-01 → 2028-07-11 3. primary completion date: 2028-04-01 → 2028-07-11

Clinical trial NCT07660432 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2027-07-01 → 2026-07-03

Clinical trial NCT06382948: enrollment: 240 → 300 participants.

Clinical trial NCT07707375 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-07-01 → 2026-07-20

Clinical trial NCT06998069: primary completion date: 2026-06-01 → 2026-12-01.

Clinical trial NCT03355976 updates: 1. completion date: 2026-09-01 → 2026-12-01 2. primary completion date: 2026-06-01 → 2026-10-01

Clinical trial NCT06385275 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 55 → 49 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07211685 updates: 1. completion date: 2028-07-27 → 2027-11-29 2. primary completion date: 2028-07-27 → 2027-11-29

Clinical trial NCT04882098: completion date: 2027-10-05 → 2027-10-06.

Clinical trial NCT07567781 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-07-01 → 2026-07-21 3. primary completion date: 2026-07-01 → 2026-07-21 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05993234: status: RECRUITING → ACTIVE_NOT_RECRUITING.

Clinical trial NCT04151667 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-07 → 2026-03-16

New Form 424B2 - TORONTO DOMINION BANK <b>Filed:</b> 2026-08-20 <b>AccNo:</b> 0001140361-26-033829 <b>Size:</b> 415 KB

Clinical trial NCT07504601: start date: 2026-08-24 → 2026-08-25.

Clinical trial NCT05335928 updates: 1. completion date: 2027-04-20 → 2029-10-09 2. primary completion date: 2026-11-20 → 2029-04-09